EXAMINE THIS REPORT ON MERCHANT ACCEPTANCE

Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs aimed at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment choices remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidate